Bumpus Namandje

Director · RXRX

As of 2026-09-27, Bumpus Namandje has 7 Form 4 transactions on record across 1 company — 3 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $477KIndirect: $0$477Kas of 2026-09-27
  • Direct $477K
  • Indirect $0
RXRXdirect127,632 sh$477K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

RXRX · 7 trades
2026-06-18: Sale, 3,963 sh ($13K)2026-06-17: Award / grant, 88,424 sh ($0)2026-06-03: Sale, 4,386 sh ($16K)2025-06-18: Award / grant, 22,016 sh ($0)2025-06-18: Award / grant, 11,008 sh ($0)2025-03-17: Award / grant, 36,549 sh ($0)2025-03-17: Award / grant, 73,099 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-06-18RXRXSale3,963 @ $3.18$13K−3.0% of holding127,632Form 4
2026-06-03RXRXSale4,386 @ $3.54$16K−9.2% of holding43,171Form 4
5 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-06-17RXRXAward / grant88,424131,595Form 4
2025-06-18RXRXAward / grant22,01622,016Form 4
2025-06-18RXRXAward / grant11,00847,557Form 4
2025-03-17RXRXAward / grant36,54936,549Form 4
2025-03-17RXRXAward / grant73,09973,099Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.